MedPath

Effectiveness of a Digital Treatment for Adolescents with Chronic Pain

Not Applicable
Not yet recruiting
Conditions
Chronic Pain
Registration Number
NCT06765200
Lead Sponsor
University Rovira i Virgili
Brief Summary

Research has shown that the prevalence of chronic pain in adolescents is high and increasing. These young people report significant changes in both their physical and psychological functioning. Currently, psychosocial treatments enjoy strong empirical support and are crucial to maintaining and improving the quality of life of adolescents suffering from chronic pain. However, the availability of these evidence-based interventions is insufficient to meet the high demand, especially outside of large cities. The aim of this project is to develop a digital treatment that helps improve the quality of life of adolescents with chronic pain and complementary websites for their parents and teachers.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
195
Inclusion Criteria
  • 12-18 years old,
  • Having a non-oncology secondary chronic pain problem,
  • Having internet access,
  • A parent willing to participate in the study,
  • Providing informed consent/assent.
Exclusion Criteria
  • Cognitive or language problems

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Pain intensitybaseline, 8 weeks, 3 months follow-up

Refers to the severity of pain an individual experiences, measured on a scale (0-10)

Pain interferencebaseline, 8 weeks, 3 months follow-up

Refers to the extent to which pain affects an individual's daily life and functioning. Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Pain Interference will be used (0-32; 0=no interference, 32=intense interference).

Global perception of change after treatment8 weeks, 3 months follow-up

refers to an individual's overall assessment of how their condition has improved or worsened following a treatment, measured on a scale (0-10).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universitat Rovira i Virgili

🇪🇸

Tarragona, Spain

© Copyright 2025. All Rights Reserved by MedPath